Actelion to discuss 9-month financial results 2009

Actelion to discuss 9-month financial results 2009

ID: 6971

(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Actelion senior management to host Q & A session 15 October 2009Dear Member of the Investment CommunityActelion Ltd will announce the 9-month financial results 2009 onTuesday, 20 October 2009, at 07.00 hrs CEST / 06.00 hrs BST / 01.00a.m. EDT. An investor conference call & webcast will be held at 15.30hrs, CEST to discuss the results.To discuss the results, Actelion will host an Investor ConferenceCall / Webcast as follows:Date/Time:20 October 2009 15.30 hrs - 16.30 hrs Basel (CEST) 14.30 hrs - 15.30 hrs U.K. (BST) 09.30 a.m. - 10.30 a.m. U.S. (EDT)Conference Call Connect #:Dial-in participants should start calling the number below 10-15minutes before the Conference is due to start.Dial: Europe: +41 44 580 64 03 U.K.: +44 203 147 47 53 U.S.: +1 866 931 15 72Participant's mode:Listen-Only with possibility to open individual lines during Q&Asession.Participants will be asked for their Name and Company.Webcast Access:Webcast participants should visit the Actelion websitehttp://www.actelion.com 10-15 minutes before the conference is due tostart. If you experience any access problems go directly to the URL:http://gaia.world-television.com/actelion/20091020/truncParticipant's mode:Listen-Only with possibility to ask individual questions by clickingon the Q&A button.Participants will be asked to provide their Name and Company.Webcast Replay:The archived Investor Webcast will be available for replay throughhttp://www.actelion.com/approximately 60 minutes after the call has ended.http://hugin.info/131801/R/1347697/324106.pdf --- End of Message ---Actelion Pharmaceuticals LtdGewerbestrasse 16 Allschwil SwitzerlandWKN: 936767; ISIN: CH0010532478; Index: SBIOM, SLIFE, SMCI, SMIEXP, SMIM, SPI, SPIEX;Listed: Main Market in SIX Swiss Exchange;



Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Third Quarter 2009 Results AIB CAPITAL EXCHANGE OFFERING 2009 - AMENDMENT TO PPS
Bereitgestellt von Benutzer: hugin
Datum: 15.10.2009 - 17:35 Uhr
Sprache: Deutsch
News-ID 6971
Anzahl Zeichen: 0

contact information:
Town:

London



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 441 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Actelion to discuss 9-month financial results 2009"
steht unter der journalistisch-redaktionellen Verantwortung von

Actelion Pharmaceuticals Ltd (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Actelion Pharmaceuticals Ltd



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z